Qyuns Therapeutics to Hold First 2026 EGM for Revised Connected-Transaction Caps and New Board Appointment

Bulletin Express10-27

Qyuns Therapeutics Co., Ltd. has issued a formal notice convening its first Extraordinary General Meeting (EGM) of 2026 on Friday, 13 November 2026 at 2:00 p.m. in Room 1809, Tower A, The Place, No. 100 Zunyi Road, Changning District, Shanghai.

Key resolutions to be tabled:

1. Revised Annual Caps for 2026-2028 • Shareholders will vote on updated annual caps for the company’s continuing connected transactions under the QX001S Framework Agreement. • The proposal also authorises any director to execute all acts and documents deemed necessary to implement the framework agreement.

2. Board Composition • The meeting will consider the appointment of Dr. Ji Juan as a non-executive director for the second session of the board, along with the remuneration package proposed by the board.

Voting logistics:

• Record Date: Holders of H shares must have their transfers registered by 4:30 p.m. on Monday, 9 November 2026 (Hong Kong time) to be eligible to vote. • Proxy Submission: Completed proxy forms and related authorisations must be lodged with Tricor Investor Services Limited by 2:00 p.m. on Thursday, 12 November 2026 (Hong Kong time). • All resolutions will be decided by poll in accordance with the company’s Articles of Association and Hong Kong Listing Rules.

The notice is authorised by Chairman and Executive Director Mr. Qiu Jiwan. As of the announcement date, the board comprises three executive directors, one non-executive director, and three independent non-executive directors.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1115333774?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-10-27 17:41","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1115333774","market":"hk","top_or_hot":-1,"title":"Qyuns Therapeutics to Hold First 2026 EGM for Revised Connected-Transaction Caps and New Board Appointment","media":"Bulletin Express","content":"<p>Qyuns Therapeutics Co., Ltd. has issued a formal notice convening its first Extraordinary General Meeting (EGM) of 2026 on Friday, 13 November 2026 at 2:00 p.m. in Room 1809, Tower A, The Place, No. 100 Zunyi Road, Changning District, Shanghai.</p>\n<p>Key resolutions to be tabled:</p>\n<p>1. Revised Annual Caps for 2026-2028  \n   • Shareholders will vote on updated annual caps for the company’s continuing connected transactions under the QX001S Framework Agreement.  \n   • The proposal also authorises any director to execute all acts and documents deemed necessary to implement the framework agreement.</p>\n<p>2. Board Composition  \n   • The meeting will consider the appointment of Dr. Ji Juan as a non-executive director for the second session of the board, along with the remuneration package proposed by the board.</p>\n<p>Voting logistics:</p>\n<p>• Record Date: Holders of H shares must have their transfers registered by 4:30 p.m. on Monday, 9 November 2026 (Hong Kong time) to be eligible to vote.  \n• Proxy Submission: Completed proxy forms and related authorisations must be lodged with Tricor Investor Services Limited by 2:00 p.m. on Thursday, 12 November 2026 (Hong Kong time).  \n• All resolutions will be decided by poll in accordance with the company’s Articles of Association and Hong Kong Listing Rules.</p>\n<p>The notice is authorised by Chairman and Executive Director Mr. Qiu Jiwan. As of the announcement date, the board comprises three executive directors, one non-executive director, and three independent non-executive directors.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Qyuns Therapeutics to Hold First 2026 EGM for Revised Connected-Transaction Caps and New Board Appointment</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nQyuns Therapeutics to Hold First 2026 EGM for Revised Connected-Transaction Caps and New Board Appointment\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-10-27 17:41</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Qyuns Therapeutics Co., Ltd. has issued a formal notice convening its first Extraordinary General Meeting (EGM) of 2026 on Friday, 13 November 2026 at 2:00 p.m. in Room 1809, Tower A, The Place, No. 100 Zunyi Road, Changning District, Shanghai.</p>\n<p>Key resolutions to be tabled:</p>\n<p>1. Revised Annual Caps for 2026-2028  \n   • Shareholders will vote on updated annual caps for the company’s continuing connected transactions under the QX001S Framework Agreement.  \n   • The proposal also authorises any director to execute all acts and documents deemed necessary to implement the framework agreement.</p>\n<p>2. Board Composition  \n   • The meeting will consider the appointment of Dr. Ji Juan as a non-executive director for the second session of the board, along with the remuneration package proposed by the board.</p>\n<p>Voting logistics:</p>\n<p>• Record Date: Holders of H shares must have their transfers registered by 4:30 p.m. on Monday, 9 November 2026 (Hong Kong time) to be eligible to vote.  \n• Proxy Submission: Completed proxy forms and related authorisations must be lodged with Tricor Investor Services Limited by 2:00 p.m. on Thursday, 12 November 2026 (Hong Kong time).  \n• All resolutions will be decided by poll in accordance with the company’s Articles of Association and Hong Kong Listing Rules.</p>\n<p>The notice is authorised by Chairman and Executive Director Mr. Qiu Jiwan. As of the announcement date, the board comprises three executive directors, one non-executive director, and three independent non-executive directors.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02509","symbol_name":"荃信生物-B","start_time":0,"source_url":"","article_id":"1115333774","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1115333774","pubTimestamp":1793094075,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Qyuns Therapeutics Co., Ltd. has issued a formal notice convening its first Extraordinary General Meeting (EGM) of 2026 on Friday, 13 November 2026 at 2:00 p.m. in Room 1809, Tower A, The Place, No....","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02509":"荃信生物-B"},"translate_title":"Qyuns Therapeutics 将召开 2026 年第一次特别股东大会，修订关联交易上限并任命新的董事会","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02509":1},"content_text":"Qyuns Therapeutics Co., Ltd. has issued a formal notice convening its first Extraordinary General Meeting (EGM) of 2026 on Friday, 13 November 2026 at 2:00 p.m. in Room 1809, Tower A, The Place, No. 100 Zunyi Road, Changning District, Shanghai.\nKey resolutions to be tabled:\n1. Revised Annual Caps for 2026-2028  \n   • Shareholders will vote on updated annual caps for the company’s continuing connected transactions under the QX001S Framework Agreement.  \n   • The proposal also authorises any director to execute all acts and documents deemed necessary to implement the framework agreement.\n2. Board Composition  \n   • The meeting will consider the appointment of Dr. Ji Juan as a non-executive director for the second session of the board, along with the remuneration package proposed by the board.\nVoting logistics:\n• Record Date: Holders of H shares must have their transfers registered by 4:30 p.m. on Monday, 9 November 2026 (Hong Kong time) to be eligible to vote.  \n• Proxy Submission: Completed proxy forms and related authorisations must be lodged with Tricor Investor Services Limited by 2:00 p.m. on Thursday, 12 November 2026 (Hong Kong time).  \n• All resolutions will be decided by poll in accordance with the company’s Articles of Association and Hong Kong Listing Rules.\nThe notice is authorised by Chairman and Executive Director Mr. Qiu Jiwan. As of the announcement date, the board comprises three executive directors, one non-executive director, and three independent non-executive directors.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.53.0","shortVersion":"4.53.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1115333774","isCrawlerRequest":true}